HIND (Vyome Holdings Inc.) Net Profit

Vyome Holdings Inc business relies on fixed R&D costs, which will ensure excess profits upon the launch of drugs via partners. The company's aggregate net income, as reported by the GURU.Markets service, demonstrates a trend where -0.01 represents the current metric. The scaling model is based on patents with low substance costs, while the current development vector is focused on mergers and the optimization of the distribution of obesity treatments.

HIND (Vyome Holdings Inc) Net Profit history from 08/16/2025 to 11/01/2026

The pricing power of Vyome Holdings Inc (HIND) in the obesity and acne treatment segment correlates directly with the financial stability reflected in the company's commercial results. This indicator captures the net daily cash flow minus all expenses, allowing investors to determine the asset's fair value through a mathematical analysis of actual returns and avoid overpaying amidst market volatility.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN: Net Income|PHAR: Company Net Income|NKTR (Nektar Therapeutics) - Net Income|Company Net Income upstreambio.com (UPB)|Company Net Income Zenas Biopharma|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|Net Income KalVista Corp KALV|Net Profit SEPN (Septerna Inc)|pieris.com (PVLA) - Company Net Income|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB: Net Profit|Astria Corp - Final Profit|Company Net Income enGene Holdings Inc.|Company Net Income rapt.com RAPT|Company Net Income Aerovate Therapeutics Inc (JBIO)|Company Net Income ACRS (Aclaris Therapeutics Inc.)|Net Profit KYTX (Kyverna)|TLSA: Company Profit|Cabaletta Bio, Inc. - Net Profit|Net Financial Result ventyxbio.com VTYX|Theratechnologies (THTX) - Company Net Income|Company Profit AVTX|ELDN (Eledon) - Net Profit|AGEN - Annual Net Income|Company Net Income Climb Bio Inc (CLYM)|Net Financial Result zurabio.com|aTyr Pharma - Net Income|Final Profit ADAG|Ikena Oncology, Inc. - Net Profit|Net Financial Result Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Company Net Income|Company Profit CNTB|IMUX (Immunic Therapeutics) - Net Profit|Net Income Atara Biotherapeutics Inc (ATRA)|Net Profit IFRX|XFOR (X4 Pharmaceuticals, Inc) - Final Profit|Net Profit ACET (Adicet Bio, Inc.)|Net Financial Result Celularity Inc (CELU)|INMB - Company Net Income|BRNS (Barinthus Biotherapeutics PLC) - Company Profit|KZR: Net Profit|Company Profit SABS|Company Net Income Akari Therapeutics|Enlivex Therapeutics, Ltd. - Profit After Tax|Net Profit QTTB|GOVX (GeoVax Labs) - Final Profit|Net Profit EDSA (Edesa)|Net Profit iBio Corporation IBIO|CARM - Company Net Income|Final Profit XTLB (xtlbio.com)|boltbio.com (BOLT) - Company Net Income|Net Income HCW Biologics|APVO (Aptevo Therapeutics, Inc.) - Net Profit|Net Profit aimimmuno.com|Net Income ADTX (Aditxt)|GRI (gribio.com) - Final Profit|Net Profit XRTX (XORTX Therapeutics)|Net Financial Result Revelation Biosciences Inc (REVB)|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|Net Income ALLK|Net Profit HOOKIPA|Company Net Income IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Company Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Company Net Income|THRD: Net Income